Merrimack Pharmaceuticals Inc. (MACK) Declined -5.66% or -0.29 To Price $4.83 On Tuesday


Merrimack Pharmaceuticals Inc. (MACK) declined -5.66% or -0.29 to $4.83. It is approximately 187011 shares traded, which is 191.62% compare to the average total volume 97593. The market cap of MACK is $64.45 million. The year to date change is 20.44%. The 52 week price range is from $3.34 to $11.7. Price of MACK have changed 6.00% during last week. It have changed 25.49% over last month, 1.59% over last 3 months, -3.40% over last 6 months and -50.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 4.33. It is -10.35% below current price. The 200-day Moving Averages for MACK is 6.08. It is 25.88% above current price. The 52-week High is 11.7. It is 142.24% from the current price. The 52-week Low is 3.34. It is -30.85% from current price.

There are some statistics of MACK. It is has market cap $64.45 million. The share outstanding is 13.34 million. The average volume is 97593. The percent of top 15 Institution holding is 63.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -49.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is -29.50%.


Tags:

Share this post